title: [Treatment with infliximab in patients with Crohn disease; experience in 132 patients].
authors.forename: S R J G
authors.initials: SR
authors.lastname: Smits
authors.forename: J A
authors.initials: JA
authors.lastname: Heijman
authors.forename: H M
authors.initials: HM
authors.lastname: van Dullemen
authors.forename: W J M J
authors.initials: WJ
authors.lastname: Rutten
authors.forename: L
authors.initials: L
authors.lastname: Annemans
authors.forename: J R B J
authors.initials: JR
authors.lastname: Brouwers
authors.forename: M J
authors.initials: MJ
authors.lastname: Postma
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D009426:Netherlands; D011306:Prescription Fees
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab